Citigroup Maintains Neutral on Physicians Realty Trust, Lowers Price Target to $14
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Michael Bilerman maintains a Neutral rating on Physicians Realty Trust (NYSE:DOC) and lowers the price target from $15 to $14.
August 22, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Citigroup has maintained a Neutral rating on Physicians Realty Trust and lowered the price target from $15 to $14.
The news directly pertains to Physicians Realty Trust (DOC) as Citigroup has maintained a Neutral rating on the company and lowered the price target. This could potentially impact the stock's performance in the short term, but the direction is uncertain as the rating is Neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100